| Quantifying the Clinical Utility of the Digital Rectal Exam in the Age of PSA Screening |
Ryan Terlecki |
Wake Forest Baptist Medical Center |
PLCO |
Jul 17, 2014 |
PLCO-97 |
| Analysis of genetic variants and lung cancer risk and prognosis |
Qingyi Wei |
Duke Cancer Institute |
PLCO |
Jul 17, 2014 |
PLCO-95 |
| Texture analysis of lung nodules |
Daniel Rubin |
Stanford University |
NLST |
Jul 14, 2014 |
NLST-80 |
| Flexible sigmoidoscopy screening in colorectal cancer: A pooled analysis of randomized controlled trials |
Robert Schoen |
University of Pittsburgh |
PLCO |
Jul 8, 2014 |
PLCO-94 |
| Applying LungRads to NLST |
Paul Pinsky |
NCI |
NLST |
Jun 24, 2014 |
NLST-79 |
| An analysis of body mass index trajectories in relation to esophageal and gastric cardia adenocarcinoma in the PLCO and NIH-AARP cohorts |
Michael Cook |
NCI, DCEG, HREB |
PLCO |
Jun 23, 2014 |
PLCO-92 |
| Upgrading and upstaging of men with clinically low-risk prostate cancer in PLCO |
Amanda Black |
NCI, DCEG, EBP |
PLCO |
Jun 23, 2014 |
PLCO-93 |
| Optimizing Early Lung Cancer Detection Utilizing Computer Vision Techniques |
Stephen Lam |
British Columbia Cancer Agency |
NLST |
Jun 18, 2014 |
NLST-78 |
| Patient Factors Associated with A Positive Finding on First CT Screening Exam |
Alex Balekian |
University of Southern California |
NLST |
Jun 6, 2014 |
NLST-76 |
| Fat intake modifies the association between smoking and lung cancer risk |
Jianjun Zhang |
Indiana University |
PLCO |
May 30, 2014 |
PLCO-87 |
| Use of Regression Discontinuity to Measure the Effect of PSA Screening |
Jonathan Shoag |
None |
PLCO |
May 28, 2014 |
PLCO-90 |
| Effect of screening on colorectal cancer incidence and mortality associated with smoking, obesity and family history of colorectal cancer |
Adeyinka Laiyemo |
Howard University |
PLCO |
May 27, 2014 |
PLCO-88 |
| The role of morphologic computed tomography characteristics in the management of subsolid nodules |
Bram van Ginneken |
Radboud University Medical Center |
NLST |
May 23, 2014 |
NLST-74 |
| Evaluating long term outcomes and over diagnosis in lung cancer screening using the PLCO data |
Dongfeng Wu |
University of Louisville |
PLCO |
May 21, 2014 |
PLCO-86 |
| ovarian cancer screening in a high risk population |
Keith Terada |
University of Hawaii |
PLCO |
May 21, 2014 |
PLCO-89 |
| The implications of polygenic risk-stratified screening for prostate cancer on overdiagnosis and cancer-specific mortality |
Nora Pashayan |
University College London |
PLCO |
May 20, 2014 |
PLCO-85 |
| Analysis of genetic variants in genome-wide level of colorectal cancer in multiple populations |
Yao Xue |
Nanjing Medical University |
PLCO |
May 20, 2014 |
PLCO-84 |
| Evaluating long term outcomes and over diagnosis in lung cancer screening using the NLST data |
Dongfeng Wu |
University of Louisville |
NLST |
May 16, 2014 |
NLST-73 |
| Redefining normal: personalized CA125 cutpoints for ovarian cancer screening |
Kathryn Terry |
Brigham and Women's Hospital / Harvard Medical School |
PLCO |
May 12, 2014 |
PLCO-82 |
| Factors affecting post lead time survival in NLST participants |
Grant Izmirlian |
National Cancer Institute |
NLST |
May 7, 2014 |
NLST-72 |
